Whistleblowing

Pharmaprime S.r.l., in accordance with D. Lgs. 24/2023 (implementing the EU Directive 2019/1937 concerning the protectio of persons who report breaches of Union law and national regulations – so-called Whistleblowing), has prepared a Whistleblowing Policy and adopted its own channel for reporting breaches and irregularities (unlawful acts and/or conduct, commission or omission, that harm the public interest or the integrity of the Company), which guarantees whistleblowers the confidentiality of their identity and the information contained in the report, as well as their protection from retaliation